Peptide
Wolverine Stack
SaveA colloquial name for the combination of BPC-157 and TB-500, popular in biohacking communities for accelerated tissue repair and recovery.
Quick verdict
Combines two individually unproven (in humans) peptides. Synergy is hypothetical based on complementary preclinical mechanisms. No clinical trials on the combination.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
No published studies on the BPC-157 + TB-500 combination. Rationale is based on complementary mechanisms: BPC-157 for GI/tendon repair and TB-500 for systemic wound healing. Entirely anecdotal in humans.
Benefits
- Complementary repair mechanisms hypothesized
- Widespread anecdotal reports of accelerated injury recovery
- Two of the most popular recovery peptides combined
Dosage notes
Community protocols: BPC-157 250–500 mcg + TB-500 2–5 mg subcutaneously. Typically run for 4–8 week cycles. Not clinically validated.
Side effects
- Injection-site reactions
- Headache
- Lethargy
- Unknown drug interactions
Who should be cautious
Neither component is approved for human use. Combining unvalidated peptides compounds the uncertainty. Product quality from gray-market sources is unreliable.
What this page cannot tell you
Synergy is speculative. Individual components lack human trial data; the combination has even less evidence.
Leaderboard scores
- Recovery50
- Pain38
Write a review
Sign in to write a review.